Hepion Pharmaceuticals, Inc. Annual Current State and Local Tax Expense (Benefit) in USD from 2016 to 2019

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Current State and Local Tax Expense (Benefit) history and growth rate from 2016 to 2019.
  • Hepion Pharmaceuticals, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$3M.
  • Hepion Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) for 2019 was -$11.4M.
  • Hepion Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) for 2017 was $1.6M, a 15.8% decline from 2016.
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2019 -$11.4M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2017 $1.6M -$300K -15.8% Jul 1, 2016 Jun 30, 2017 10-KT 2018-03-26
2016 $1.9M Jul 1, 2015 Jun 30, 2016 10-KT 2018-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.